Michael R. Migden, MD, FAAD
SESSIONS
F011 What's New in the Management of Advanced Skin Cancer
Mar 27, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 2D
DISCLOSURES
Feldan Therapeutics – Consultant (1099 relationship)(Fees); Philogen S.p.A. – Consultant (1099 relationship)(Fees); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Replimune – Consultant (1099 relationship)(Fees); Stamford Pharmaceuticals – Consultant (1099 relationship)(Fees); Sun Pharmaceuticals – Consultant (1099 relationship)(Fees);